Conservative therapy of inflammatory diseases of large intenstine

Title:

Conservative therapy of inflammatory diseases of large intenstine
Conservative therapy of inflammatory diseases of large intenstine

Creator:

Matkarimov, S. R., Rustamov, A. E., and Rahmon, S. T.

Contributor:

Matkarimov, S. R., Rustamov, A. E., and Rahmon, S. T.

Identifier:

https://cdk.lib.cas.cz/client/handle/uuid:bmc14045873-a91e67c5-1bd6-4b21-9b67-7abf7b078d5b
uuid:bmc14045873-a91e67c5-1bd6-4b21-9b67-7abf7b078d5b
local:bmc14045873
http://ojs.journals.cz/index.php/EMHPJ/issue/archive
local: bmc14045873

Subject:

Crohnova nemoc--terapie, ulcerózní kolitida--terapie, mesalamin--terapeutické užití, monoklonální protilátky--terapeutické užití, nemoci tlustého střeva--terapie, výsledek terapie, mladiství, dospělí, ženské pohlaví, lidé, mužské pohlaví, lidé středního věku, and mladý dospělý

Type:

model:article, article, Text, statistics, and TEXT

Format:

braille, electronic resource, remote, and elektronický zdroj

Description:

The target of research was the implementation of the comparative analysis of conservative therapy of preparation of basic therapy and also new methods of treatment (anticytokine therapy). Appointment of salofalk in twos tablets (0, 5) 34 times a day per os, and also 2,0 gr in the form of a rectal enema unitary for a period of seven days, then had transferd the patients to reception 2,0 gr salofalk per os, allowed to achieve substantial improvement patients’ cliniclaboratory and endoscopic symptoms with a heavy intensification of ulcer colitis variation, providing full cliniclabaratory remissions achievements of disease at 8 (34 %) patients. In the Minister of the Uzbek Public Health of the Republican Science Coloproctological Center at 10 patients with the IDI have spent the therapy remicade, 7 of them had NUC and 3 patients had the Crohn's disease. Therefore, all patients no longer than on the first week after introduction of remicade had improvement of a course disease which was expressed in defering stool, extinction or reduction of pathological impurity in excrement and subsidence bellyaches. During colonoscopical inspection, in 1218 weeks after the first infusion at 80% of the patients had observed disappearance of ulcers and erosion. In terms of 6 months of supervision of relapse of disease was not noted. All new directions in treatment of the IDI, apparently, are perspective, but while are proved only theoretically and had no practical development. Unique and enough effective and safe method at the IDI and already has clinical acknowledgement is remicade., Matkarimov S. R., Rustamov A. E., Rahmonov S. T., and Literatura

Language:

English

Rights:

http://creativecommons.org/publicdomain/mark/1.0/
policy:public

Relation:

European medical, health and pharmaceutical journal--MED00177703

Source:

European medical, health and pharmaceutical journal : open access reviewed journal | 2010 Volume:2010 | Number:1

Harvested from:

CDK

Metadata only:

false

Date:

2010